Robin Stuart‐Harris

Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE)

Thomas Bachelot, Eva Ciruelos, Fabio Puglisi et al. · Annals of Oncology · 2019 · 113 citations · Full text

Medicine, Oncology, Pharmacology +17

Prediction of life-expectancy in hospice patients: identification of novel prognostic factors

Mark Rosenthal, Val Gebski, Richard Kefford et al. · Palliative Medicine · 1993 · 98 citations

Nursing, Geriatric Medicine, Hospice Care +15

Mitoxantrone for the treatment of advanced breast cancer: Single-agent therapy in previously untreated patients

M A Cornbleet, Robin Stuart‐Harris, Ian E. Smith et al. · European Journal of Cancer and Clinical Oncology · 1984 · 78 citations

Medicine, Oncology, Pharmacology +9

The management of cytotoxic‐drug extravasation: guide‐lines drawn up by a working party for the Clinical Oncological Society of Australia

Keith Cox, Grace Abdini, John J. Grygiel et al. · The Medical Journal of Australia · 1988 · 72 citations

Medicine, Oncology, Pharmacology +14

What survival benefits do premenopausal patients with early breast cancer need to make endocrine therapy worthwhile?

Belinda Thewes, Bettina Meiser, V. Duric et al. · The Lancet Oncology · 2005 · 65 citations · Full text

Medicine, Endocrinology, Oncology +17